EHP-101 (VCE-004.8) is an orally active, specific PPARgamma and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101 attenuates adipogenesis and prevents diet-induced obesity. EHP-101 (20?mg/kg/day, i.
Molecular Weight:
433.5824
CAS Number:
[1818428-24-8]
Formula:
C28H35NO3
* VAT and and shipping costs not included. Errors and price changes excepted